Lung Structure and Risk of Sleep Apnea in SPIROMICS.

Rationale: The SubPopulations and InteRmediate Outcome Measures in COPD Study (SPIROMICS) is a prospective cohort study that enrolled 2981 participants with the goal of identifying new chronic obstructive pulmonary disease (COPD) subgroups and intermediate markers of disease progression. Individuals with COPD and obstructive sleep apnea (OSA) experience impaired quality of life and more frequent exacerbations. COPD severity also associates with computed tomography scan-based emphysema and alterations in airway dimensions. Objectives: The objective was to determine whether the combination of lung function and structure influences the risk of OSA among current and former smokers. Methods: Using 2 OSA risk scores, the Berlin Sleep Questionnaire (BSQ), and the DOISNORE50 <em>(Diseases, Observed apnea, Insomnia, Snoring, Neck circumference &gt; 18 inches, Obesity with body mass index [BMI] &gt; 32, R = are you male, Excessive daytime sleepiness, 50 = age &ge; 50)</em> (DIS), 1767 current and former smokers were evaluated for an association of lung structure and function with OSA risk. Measurements and Main Results: The study cohort's mean age was 63 years, BMI was 28 kg/m2, and forced expiratory volume in 1 second (FEV1) was 74.8% predicted. The majority were male (55%), White (77%), former smokers (59%), and had COPD (63%). A high-risk OSA score was reported in 36% and 61% using DIS and BSQ respectively. There was a 9% increased odds of a high-risk DIS score (odds ratio [OR]=1.09, 95% confidence interval [CI]:1.03-1.14) and nominally increased odds of a high-risk BSQ score for every 10% decrease in FEV1 %predicted (OR=1.04, 95%CI: 0.998-1.09). Lung function-OSA risk associations persisted after additionally adjusting for lung structure measurements (%emphysema, %air trapping, parametric response mapping for functional small airways disease, , mean segmental wall area, tracheal %wall area, dysanapsis) for DIS (OR=1.12, 95%CI:1.03-1.22) and BSQ (OR=1.09, 95%CI:1.01-1.18). Conclusions: Lower lung function independently associates with having high risk for OSA in current and former smokers. Lung structural elements, especially dysanapsis, functional small airways disease, and tracheal %wall area strengthened the effects on OSA risk.

Authors

Institutions

Publication Details

Journal
UNC Libraries
Published
2025-07-30
DOI
https://doi.org/10.17615/z6r0-7x34
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lung Structure and Risk of Sleep Apnea in SPIROMICS.

Eric A. Hoffman, Russell Paul Bowler, Igor Barjaktarević, MeiLan K. Han et al.
UNC Libraries
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Lung Structure and Risk of Sleep Apnea in SPIROMICS.

Eric A. Hoffman, Russell Paul Bowler, Igor Barjaktarević, MeiLan K. Han, Richard E. Kanner, Amit Saha, Aaron Baugh, Tracie L. Shing, Benjamin M. Smith, Victor E. Ortega, Surya Prakash Bhatt, Stephen P. Peters, Andrew M. Namen, Nirupama Putcha, Prescott G. Woodruff, Nadia N. Hansel, Jerry A. Krishnan, Alejandro P. Comellas, Abigail L. Koch, David Couper, Fernando J. Martínez, Victor Kim, R. Graham Barr, Robert Paine, Christopher B. Cooper, Michelle Ziedler
article en

Abstract

Rationale: The SubPopulations and InteRmediate Outcome Measures in COPD Study (SPIROMICS) is a prospective cohort study that enrolled 2981 participants with the goal of identifying new chronic obstructive pulmonary disease (COPD) subgroups and intermediate markers of disease progression. Individuals with COPD and obstructive sleep apnea (OSA) experience impaired quality of life and more frequent exacerbations. COPD severity also associates with computed tomography scan-based emphysema and alterations in airway dimensions. Objectives: The objective was to determine whether the combination of lung function and structure influences the risk of OSA among current and former smokers. Methods: Using 2 OSA risk scores, the Berlin Sleep Questionnaire (BSQ), and the DOISNORE50 <em>(Diseases, Observed apnea, Insomnia, Snoring, Neck circumference &gt; 18 inches, Obesity with body mass index [BMI] &gt; 32, R = are you male, Excessive daytime sleepiness, 50 = age &ge; 50)</em> (DIS), 1767 current and former smokers were evaluated for an association of lung structure and function with OSA risk. Measurements and Main Results: The study cohort's mean age was 63 years, BMI was 28 kg/m2, and forced expiratory volume in 1 second (FEV1) was 74.8% predicted. The majority were male (55%), White (77%), former smokers (59%), and had COPD (63%). A high-risk OSA score was reported in 36% and 61% using DIS and BSQ respectively. There was a 9% increased odds of a high-risk DIS score (odds ratio [OR]=1.09, 95% confidence interval [CI]:1.03-1.14) and nominally increased odds of a high-risk BSQ score for every 10% decrease in FEV1 %predicted (OR=1.04, 95%CI: 0.998-1.09). Lung function-OSA risk associations persisted after additionally adjusting for lung structure measurements (%emphysema, %air trapping, parametric response mapping for functional small airways disease, , mean segmental wall area, tracheal %wall area, dysanapsis) for DIS (OR=1.12, 95%CI:1.03-1.22) and BSQ (OR=1.09, 95%CI:1.01-1.18). Conclusions: Lower lung function independently associates with having high risk for OSA in current and former smokers. Lung structural elements, especially dysanapsis, functional small airways disease, and tracheal %wall area strengthened the effects on OSA risk.

UNC Libraries
University of North Carolina at Chapel Hill (US)
U.S. Department of Defense, U.S. Department of Veterans Affairs, American Thoracic Society, Amgen, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Gilead Sciences, Biogen, Teva Pharmaceutical Industries, Array BioPharma, Chiesi Farmaceutici, COPD Foundation, Dartmouth College, CSL Behring, McGill University, Sunovion, Regeneron Pharmaceuticals, McGill University Health Centre, Mylan, ResMed, Veracyte, Glenmark Pharmaceuticals, York University, Canadian Lung Association, Grifols, National Institutes of Health, Genentech, Gillings School of Public Health, University of North Carolina at Chapel Hill, Canadian Institutes of Health Research, National Heart, Lung, and Blood Institute
Openalex Percentile: Top 51%
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.